Sernova Corp.

TSX:SVA.TO

Biotechnology

Healthcare
$0.14 -5.88%

-$0.01 today

Market cap
$50.98M
Beta
0.66
P/E (TTM)
-4.7
EPS (TTM)
-$0.03
52W Low $0.12High $0.21

Volume 0.55M

Average 0.12M

SVA.TO Total Debt

Short-term and long-term borrowings combined.

Sernova Corp.TSX: SVA.TO

Total Debt · Q2 FY2026 · quarter ended Apr 2026

Total debt falls 48.2% from a year ago

Total debt stood at CA$2.45M at the end of Q2 FY2026, down 48.2% from a year earlier and down 86.0% from the prior quarter. Over 3 fiscal years it compounded at +297.1% a year.

Context

  • Total debt amounted to 159.9% of total assets at the end of Q2 FY2026, up 37.6 pp from a year earlier.
  • Total debt increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -48.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
CA$2.45M-86.0% QoQ
Last fiscal yearOct 2025
CA$17.28M+2932.2% YoY
Year agoApr 2025
CA$4.74M-48.2% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-48.2%——
1 year+2932.2%——
3-year CAGR+297.1%——
5-year CAGR——
10-year CAGR——

Total Debt history

CAD · from the balance sheet

Latest · FY2025
17.28M CAD
Year-over-year change
+2932.2%
4-year CAGR
+157.5%

Total Debt vs competitors

How SVA.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Total debt amounts to 159.9% of total assets for SVA.TO, versus a peer median of 0.0%.
SVA.TO Competitors
Total Debt for SVA.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SVA.TOSernova Corp.Apr 2026CA$2.45M CAD-48.2%+297.1%159.9%
BCT.TOBriaCell Therapeutics Corp.Apr 2026$0 USD——0.0%
Peer median (excluding SVA.TO) ———0.0%

Competitors are the stored peer set for SVA.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Cash & Equivalents27.87M3.78M8.72M6.01M265K
Short-term Investments046M11.08M00
Net Receivables448.95K1.15M1.05M298.1K122.63K
Inventory00000
Other Current Assets000159.17K135.01K
Total Current Assets28.33M51.09M21.02M6.47M522.65K
Property, Plant & Equipment (Net)176.33K653.7K507.44K833.93K17.72K
Goodwill00000
Intangible Assets716.79K516.75K316.72K00
Long-term Investments00000
Tax Assets00000
Other Non-current Assets599.89K223.86K259.16K223.86K223.86K
Total Non-current Assets1.49M1.39M1.08M1.06M241.58K
Total Assets29.82M52.48M22.11M7.53M764.23K
Account Payables379.52K3.61M6.85M17.24M0
Short-term Debt000016.24M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities287.77K4.6M757.27K19.91M8.56M
Total Current Liabilities1.48M4.74M9.59M20.02M24.8M
Long-term Debt00001.04M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities275.98K136.12K0468.48K1.04M
Total Liabilities1.75M4.88M9.59M20.48M25.84M
Common Stock74.01M110.99M110.99M116.68M118.7M
Retained Earnings(54.75M)(79.17M)(118.17M)(150.36M)(166.1M)
Accumulated OCI3.69M3.3M00537.14K
Other Stockholders Equity00035.07K0
Minority Interest00000
Total Equity28.07M47.61M12.51M(12.96M)(25.08M)
Total Debt393.35K275.98K136.12K569.94K17.28M
Net Debt(27.48M)(3.5M)(8.59M)(5.44M)17.02M

Sernova Corp.

TSX:SVA.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.14

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.